Literature DB >> 21248786

Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene.

Vicki Huff1.   

Abstract

Genes identified as being mutated in Wilms' tumour include TP53, a classic tumour suppressor gene (TSG); CTNNB1 (encoding β-catenin), a classic oncogene; WTX, which accumulating data indicate is a TSG; and WT1, which is inactivated in some Wilms' tumours, similar to a TSG. However, WT1 does not always conform to the TSG label, and some data indicate that WT1 enhances cell survival and proliferation, like an oncogene. Is WT1 a chameleon, functioning as either a TSG or an oncogene, depending on cellular context? Are these labels even appropriate for describing and understanding the function of WT1?

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21248786      PMCID: PMC4332715          DOI: 10.1038/nrc3002

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  107 in total

1.  Role of the WT1 tumor suppressor in murine hematopoiesis.

Authors:  Julia A Alberta; Gregory M Springett; Helen Rayburn; Thomas A Natoli; Janet Loring; Jordan A Kreidberg; David Housman
Journal:  Blood       Date:  2002-12-05       Impact factor: 22.113

2.  Expression of the Wilms' tumor gene (WT1) in normal hemopoiesis.

Authors:  P N Baird; P J Simmons
Journal:  Exp Hematol       Date:  1997-04       Impact factor: 3.084

3.  Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin.

Authors:  Ofelia M Martínez-Estrada; Laura A Lettice; Abdelkader Essafi; Juan Antonio Guadix; Joan Slight; Víctor Velecela; Emma Hall; Judith Reichmann; Paul S Devenney; Peter Hohenstein; Naoki Hosen; Robert E Hill; Ramón Muñoz-Chapuli; Nicholas D Hastie
Journal:  Nat Genet       Date:  2009-12-20       Impact factor: 38.330

4.  SUMO-1 modification of the Wilms' tumor suppressor WT1.

Authors:  Gromoslaw A Smolen; Maria T Vassileva; Julie Wells; Michael J Matunis; Daniel A Haber
Journal:  Cancer Res       Date:  2004-11-01       Impact factor: 12.701

5.  Mice lacking the 68-amino-acid, mammal-specific N-terminal extension of WT1 develop normally and are fertile.

Authors:  Colin G Miles; Joan Slight; Lee Spraggon; Maureen O'Sullivan; Charles Patek; Nicholas D Hastie
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

6.  WNT/beta-catenin pathway activation in Wilms tumors: a unifying mechanism with multiple entries?

Authors:  Marie Corbin; Aurélien de Reyniès; David S Rickman; Dominique Berrebi; Liliane Boccon-Gibod; Sarah Cohen-Gogo; Monique Fabre; Francis Jaubert; Marine Faussillon; Funda Yilmaz; Sabine Sarnacki; Judith Landman-Parker; Catherine Patte; Gudrun Schleiermacher; Corinne Antignac; Cécile Jeanpierre
Journal:  Genes Chromosomes Cancer       Date:  2009-09       Impact factor: 5.006

7.  Relaxation of imprinted genes in human cancer.

Authors:  S Rainier; L A Johnson; C J Dobry; A J Ping; P E Grundy; A P Feinberg
Journal:  Nature       Date:  1993-04-22       Impact factor: 49.962

8.  Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling.

Authors:  Michael B Major; Nathan D Camp; Jason D Berndt; Xianhua Yi; Seth J Goldenberg; Charlotte Hubbert; Travis L Biechele; Anne-Claude Gingras; Ning Zheng; Michael J Maccoss; Stephane Angers; Randall T Moon
Journal:  Science       Date:  2007-05-18       Impact factor: 47.728

9.  Expression of the Wilms' tumor gene (WT1) in human leukemias.

Authors:  H Miwa; M Beran; G F Saunders
Journal:  Leukemia       Date:  1992-05       Impact factor: 11.528

10.  RNA expression of the WT1 gene in Wilms' tumors in relation to histology.

Authors:  H Miwa; G E Tomlinson; C F Timmons; V Huff; S L Cohn; L C Strong; G F Saunders
Journal:  J Natl Cancer Inst       Date:  1992-02-05       Impact factor: 13.506

View more
  95 in total

1.  WTX: an unexpected regulator for p53.

Authors:  Chao Dai; Wei Gu
Journal:  Mol Cell       Date:  2012-03-09       Impact factor: 17.970

Review 2.  Evaluation of current cancer immunotherapy: hemato-oncology.

Authors:  Christopher S Hourigan; Hyam I Levitsky
Journal:  Cancer J       Date:  2011 Sep-Oct       Impact factor: 3.360

3.  Common variants at 11p13 are associated with susceptibility to tuberculosis.

Authors:  Thorsten Thye; Ellis Owusu-Dabo; Fredrik O Vannberg; Reinout van Crevel; James Curtis; Edhyana Sahiratmadja; Yanina Balabanova; Christa Ehmen; Birgit Muntau; Gerd Ruge; Jürgen Sievertsen; John Gyapong; Vladyslav Nikolayevskyy; Philip C Hill; Giorgio Sirugo; Francis Drobniewski; Esther van de Vosse; Melanie Newport; Bachti Alisjahbana; Sergey Nejentsev; Tom H M Ottenhoff; Adrian V S Hill; Rolf D Horstmann; Christian G Meyer
Journal:  Nat Genet       Date:  2012-02-05       Impact factor: 38.330

4.  HuR antagonizes the effect of an intronic pyrimidine-rich sequence in regulating WT1 +/-KTS isoforms.

Authors:  Hui Li; Shuai Hou; Tian Hao; Sikandar Azam; Caigang Liu; Lei Shi; Haixin Lei
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

5.  Ligand-dependent corepressor (LCoR) recruitment by Kruppel-like factor 6 (KLF6) regulates expression of the cyclin-dependent kinase inhibitor CDKN1A gene.

Authors:  Mario R Calderon; Mark Verway; Beum-Soo An; Analisa DiFeo; Tarek A Bismar; David K Ann; John A Martignetti; Tali Shalom-Barak; John H White
Journal:  J Biol Chem       Date:  2012-01-25       Impact factor: 5.157

Review 6.  RNA activation technique and its applications in cancer research.

Authors:  Xiao-Yu Wang; Long Yuan; Yan-Ling Li; Si-Jie Gan; Lin Ren; Fan Zhang; Jun Jiang; Xiao-Wei Qi
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

7.  A Murine Model of K-RAS and β-Catenin Induced Renal Tumors Expresses High Levels of E2F1 and Resembles Human Wilms Tumor.

Authors:  Yajun Yi; Dina Polosukhina; Harold D Love; Austin Hembd; Michael Pickup; Harold L Moses; Harold N Lovvorn; Roy Zent; Peter E Clark
Journal:  J Urol       Date:  2015-04-29       Impact factor: 7.450

8.  Association between WT1 polymorphisms and susceptibility to breast cancer: results from a case-control study in a southwestern Chinese population.

Authors:  Xiao-Wei Qi; Xiao-Dong Zheng; Bei-Ge Zong; Qing-Qiu Chen; Fan Zhang; Xin-Hua Yang; Yi Zhang; Jun-Lan Liu; Jun Jiang
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

9.  Wt1 dictates the fate of fetal and adult Leydig cells during development in the mouse testis.

Authors:  Qing Wen; Qiao-Song Zheng; Xi-Xia Li; Zhao-Yuan Hu; Fei Gao; C Yan Cheng; Yi-Xun Liu
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-10-21       Impact factor: 4.310

10.  Molecular and epidemiologic characterization of Wilms tumor from Baghdad, Iraq.

Authors:  Hannah M Phelps; Mazin F Al-Jadiry; Natasha M Corbitt; Janene M Pierce; Bingshan Li; Qiang Wei; Raina R Flores; Hernan Correa; Stefania Uccini; Haydar Frangoul; Adel R Alsaadawi; Safaa A F Al-Badri; Amir F Al-Darraji; Raghad M Al-Saeed; Salma A Al-Hadad; Harold N Lovvorn Iii
Journal:  World J Pediatr       Date:  2018-08-28       Impact factor: 2.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.